Dr. Vikas Ghai

Ather Mehboob is a Hematologist and an Oncologist in Bakersfield, California. Dr. Mehboob is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer.

Ricardo Salas is a Hematologist Oncology specialist and a Hematologist in Bakersfield, California. Dr. Salas is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Large-Cell Immunoblastic Lymphoma.

Dr. Ravi Patel is a board certified Medical Oncologist who has been practicing for more than 30 years. He completed his residency at the University of Illinois after obtaining a medical degree from Gujarat University Medical College in India. He went on to complete a fellowship in Hematology/ Oncology from Loyola University Stritch School of Medicine.From the early stages of his career, Dr. Patel was exposed to and focused on bone marrow transplantation along with a wide variety of oncology and hematology training.Dr. Patel founded Comprehensive Blood & Cancer Center in 1984, growing it from a 1,200 square foot office with one employee into the comprehensive, community focused, diagnostic, treatment, educational and research-based cancer center it is today with over 250 employees and a 120,000 square foot campus.While serving as managing director of the center, Dr. Patel continues to actively care for his patients and serve as principal investigator on the center's many clinical research studies. Dr. Patel is actively involved with the leading pharmaceutical manufacturers and academic research programs to assure that cancer patients in Kern County have access to the most cutting-edge medicines and treatments available anywhere in the world.Through choosing to work with the UCLA Jonsson Comprehensive Cancer Center TRIO-US Network, UCLA employees manage clinical trials alongside CBCC's own research staff. Several of the treatments tested at CBCC have proven to be highly successful and have gone on to receive approval from the Federal Government's Food and Drug Administration (FDA). These breakthrough treatments have changed the way many forms of cancer are now being managed around the world.As a result of his clinical research experience, Dr. Patel has authored several scientific papers in such respected journals as the Journal of Clinical Oncology and Clinical Lymphoma. He is sought after as a lecturer and consultant on clinical oncology issues and patient care. He serves as an Associate Clinical Professor of Medicine at UCLA and is actively involved with the Residency Program in Internal Medicine at the Kern County Medical Center. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Breast Cancer, Ampullary Cancer, Paget Disease of the Breast, and Diffuse Large B-Cell Lymphoma (DLBCL).